Rossana Di Rienzo
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.
Journal: Clinical breast cancer
Published: April 22, 2026
The long road after breast cancer: survivorship issues and long-term treatment effects in young women.
Journal: Frontiers in oncology
Published: March 27, 2026
Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
Journal: JCO clinical cancer informatics
Published: March 06, 2026
Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives.
Journal: Cancer treatment reviews
Published: August 21, 2025
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 24, 2025
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients.
Journal: Breast (Edinburgh, Scotland)
Published: January 09, 2024
Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome.
Journal: Cancer treatment reviews
Published: June 23, 2023
The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer.
Journal: Cancer treatment reviews
Published: October 08, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026